Kovitz Investment Group Partners, LLC Abb Vie Inc. Call Options Transaction History

Kovitz Investment Group Partners, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $3,375 - $3,716	33 Added 18.03%	216 $463,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $14,488 - $19,560	-180 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $429 - $504	5 Added 2.86%	180 $159,000
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $12,839 - $17,181	175 New	175 $294,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.